TFF3 Rat

Trefoil Factor-3 Rat Recombinant
Shipped with Ice Packs
In Stock

Description

Chemical Synthesis

TFF3 and its homodimer were synthesized using native chemical ligation (NCL) and oxidative folding :

  • Fragmentation: Split into N-terminal (TFF3<sub>1–35</sub>) and C-terminal (TFF3<sub>36–59</sub>) fragments.

  • Ligation: Achieved 15–20% yields after purification .

  • Folding: Confirmed via NMR and circular dichroism, showing no cytotoxicity or hemolytic activity .

Gastrointestinal Stability

TFF3 FormHalf-life in SGF/SIFBioactive Metabolite
Full-length TFF3<5 minTFF3<sub>7–54</sub>
TFF3 Homodimer~40 minTFF3<sub>7–54</sub>
TFF3 Trefoil Domain<30 minNon-stable
TFF3<sub>7–54</sub>>24 hRetains antiapoptotic activity

TFF3<sub>7–54</sub>, a gut-stable metabolite, retains the trefoil structure and antiapoptotic function despite truncation of terminal residues .

Gastrointestinal Diseases

  • Colitis: Intracolonic TFF3 dimers (10 µg/day) reduced inflammation in DSS-induced colitis, while monomers showed no effect .

  • Epithelial Repair: TFF3<sup>−/−</sup> rats exhibited delayed corneal healing (462 vs. 98 h in wild-type), reversible with exogenous TFF3 .

3.2.1 Type 2 Diabetes (T2DM)

  • Serum Levels: Elevated in diabetic rats and correlated with insulin resistance .

  • Therapeutic Effect: Adenoviral TFF3 overexpression reduced blood glucose by 30% via AKT-mediated inhibition of gluconeogenic genes .

3.2.2 Non-Alcoholic Fatty Liver Disease (NAFLD)

InterventionOutcome in RatsMechanism
Recombinant TFF3 injection↓ Hepatic lipid vesicles by 40%↑ PPAR-α fatty acid oxidation
TFF3 knockdown↑ Lipid accumulation, ↓ metabolic genesDisrupted lipid droplet formation

Neurological Effects

  • Antidepressant Action: Intra-amygdala TFF3 (0.1 µg) reduced depressive behaviors by 50% via BDNF/ERK pathways .

  • Neuroinflammation: TFF3 suppressed LPS-induced proinflammatory cytokines (IL-6, TNF-α) in rat microglia by 60% .

Key Applications

  • Colitis Treatment: TFF3 dimers as mucosal protectants .

  • NAFLD Management: Recombinant TFF3 reduces hepatic steatosis .

  • Neuropsychiatric Disorders: Low-dose TFF3 as an anxiolytic agent .

Challenges

  • Delivery: Oral administration requires stabilization against proteolysis (e.g., TFF3<sub>7–54</sub>) .

  • Dose Dependency: High-dose TFF3 exacerbates anxiety in rats .

Product Specs

Introduction
The TFF (Trefoil Factor) family of proteins is defined by the presence of at least one trefoil motif, a 40-amino acid domain containing three conserved disulfide bonds. These proteins are secreted by mucosal tissues in the gastrointestinal tract, where they provide protection against injury, stabilize the mucus layer, and promote epithelial healing. TFF2 specifically acts to inhibit gastric acid secretion and motility while also stabilizing mucus glycoproteins through interactions with carbohydrate side chains. TFF3, on the other hand, is involved in airway epithelial cell differentiation by inducing ciliogenesis, a process it facilitates largely through an epidermal growth factor receptor-dependent pathway. Importantly, TFF3 overexpression has been linked to the progression of hepatocellular carcinogenesis in both mice and humans, with its expression level correlating with tumor grade.
Description
This product is a recombinant Trefoil Factor-3 protein of rat origin (TFF3 Rat). It has been engineered with a C-terminal Flag-tag (9 amino acids total: 1 N-terminal + 8 C-terminal) and produced in E. coli. The resulting protein is 7.7 kDa in size and comprises 68 amino acid residues.
Physical Appearance
The product appears as a white lyophilized (freeze-dried) powder after filtration.
Formulation
The TFF3 protein undergoes filtration (0.4 µm) and is subsequently lyophilized at a concentration of 0.5 mg/ml in a buffer solution of 20 mM TRIS and 50 mM NaCl, pH 7.5.
Solubility
To prepare a working stock solution, it is recommended to add deionized water to the lyophilized pellet and allow it to dissolve completely until a concentration of approximately 0.5 mg/ml is achieved. Note: This product is not sterile. Before use in cell culture, it must be filtered through an appropriate sterile filter.
Stability
For long-term storage, keep the lyophilized protein at -20°C. After reconstitution, aliquot the product to minimize repeated freeze/thaw cycles. Reconstituted protein remains stable at 4°C for a limited period and has shown no significant changes over two weeks when stored at this temperature.
Purity
The purity of this product is greater than 95.0% as determined by SDS-PAGE analysis.
Synonyms
Trefoil factor 3, Intestinal trefoil factor, rITF, Polypeptide P1.B, rP1.B, Tff3, Itf.
Source
Escherichia Coli.
Amino Acid Sequence
MQEFVGLSPS QCMVPANVRV DCGYPTVTSE QCNNRGCCFD SSIPNVPWCF KPLQETECT F DYKDDDDK.

Q&A

What is TFF3 and where is it primarily expressed in rat tissues?

TFF3 belongs to the trefoil factor family, characterized by one or more three-looped structural motifs resembling a three-leaf clover. In rats, TFF3 is primarily expressed in the intestine and colon of the gastrointestinal tract, with cells invariably associated with glycoprotein biosynthesis and secretion . Research has identified both TFF3 mRNA and peptide in rat lymphoid tissues, demonstrating expression beyond the digestive system . The TFF family consists of three known mammalian members (TFF1, TFF2, and TFF3), with distinct tissue distribution patterns - TFF1 and TFF2 are primarily expressed in the stomach, while TFF3 predominates in intestinal and colonic tissues .

What are the primary biological functions of TFF3 in rat models?

In rat models, TFF3 demonstrates multiple critical physiological functions:

  • Mucosal defense through both protective and reparative mechanisms

  • Immune response participation, with studies showing a 1.5 to 3-fold increase in TFF peptide expression in rat spleen following experimental immune response induction

  • Cell migration stimulation, contributing to tissue repair functionality

  • Anti-apoptotic activity, as evidenced by stability and bioactivity studies

  • Modulation of inflammatory responses, suggesting roles in maintaining tissue homeostasis

Research indicates that TFF3 contributes to repair of injury specifically through modulation of inflammatory pathways . The trefoil domain of TFF3 appears to be the essential functional region, as fragments containing this domain retain anti-apoptotic activity .

How does TFF3 structurally exist in rat tissues and what are the implications?

TFF3 exists in both monomeric and homodimeric forms in rat tissues:

FormStructureStabilityFunctional Implications
MonomerSingle TFF3 peptideLess stable in GI environmentBasic anti-apoptotic activity
HomodimerTwo TFF3 peptides linked via Cys57-Cys57 disulfide bondGreater stabilityEnhanced functional properties, potential oncogenic function

The homodimeric form is created through a disulfide bond at the Cys57 residue . Chemical synthesis techniques can produce both the monomer (TFF3(C57Acm)), which cannot dimerize under physiological conditions, and the TFF3 homodimer . This structural difference has significant functional implications, as the homodimer shows enhanced stability and potentially different signaling properties compared to the monomer . Pharmacological targeting of the homodimeric form has shown potential in cancer research .

How is TFF3 expression modulated during inflammation in rat models?

During inflammation in rats, TFF3 expression undergoes significant modulation. Studies have demonstrated that TFF peptide expression in rat spleen increased 1.5- to 3-fold following experimental induction of the immune response . This upregulation suggests TFF3 has important roles in:

  • Inflammatory response regulation

  • Tissue repair following injury

  • Modulation of immune cell activity

The exact mechanisms and signaling pathways involved in this upregulation remain an area of active research, but evidence suggests TFF3 may be involved in the repair of injury through specific modulation of inflammatory response pathways . This makes TFF3 a potential therapeutic target for inflammatory conditions.

What is the relationship between TFF3 and mucins in rat gastrointestinal tissue?

In rat gastrointestinal tissue, TFF3 maintains a close functional and structural relationship with mucins:

  • TFF3 expression is invariably associated with extensive glycoprotein biosynthesis and secretion

  • TFF3 localizes to mucus-secreting cells of the gastrointestinal mucosa

  • Both structural and functional associations between mucus glycoproteins and TFF3 have been proposed

This relationship appears to be of widespread physiological importance, potentially contributing to the integrity and protective functions of the mucosal barrier . TFF3's interaction with mucins may enhance the viscoelastic properties of the mucus and contribute to its protective effects against various forms of mucosal damage.

What are the molecular mechanisms through which TFF3 mediates tissue repair in rat models?

The molecular mechanisms underlying TFF3-mediated tissue repair in rat models involve complex signaling networks:

  • Cell migration stimulation through modulation of EGFR, p38, STAT3, AKT, and ERK signaling pathways

  • Anti-apoptotic effects through regulation of:

    • Cell cycle regulators (CCND1, CCNE1)

    • Anti-apoptotic proteins (BCL2, BCL-XL)

    • Pro-apoptotic factors (CASP7, CASP9)

  • Trefoil domain functionality is essential for bioactivity

Research has demonstrated that TFF3 homodimer monomerization by compounds such as AMPC leads to decreased activity of critical signaling molecules (EGFR, p38, STAT3, AKT, and ERK) with subsequent apoptotic effects . This suggests that the dimeric form of TFF3 maintains anti-apoptotic signaling, whereas monomeric forms may have reduced activity in this regard.

What methodological approaches can reliably detect and quantify TFF3 in rat tissue samples?

Multiple complementary methodological approaches can be employed for reliable TFF3 detection in rat tissues:

Detection TargetTechniqueAdvantagesConsiderations
mRNART-PCR, in situ hybridizationHigh sensitivity, spatial distributionPost-transcriptional regulation may affect correlation with protein levels
Protein (total)ELISA, Western blottingQuantitative, relatively high throughputMay not distinguish monomeric/dimeric forms
Protein (localization)ImmunohistochemistryProvides spatial contextRequires specific antibodies
Monomeric vs. Dimeric formsNon-reducing Western blottingDistinguishes structural variantsTechnical challenges in maintaining native structure
Structural analysisNMR, circular dichroismConfirms proper foldingRequires purified protein

When designing TFF3 detection experiments, it's crucial to consider that TFF3 can exist in both monomeric and homodimeric forms . NMR and circular dichroism analyses have been successfully used to confirm the correct fold of synthetic TFF3, showing characteristic α-helical structure with negative bands at 222 and 208 nm and a positive band at 193 nm .

How does TFF3 expression in rats compare to human TFF3 expression patterns?

TFF3 expression patterns show notable similarities and differences between rats and humans:

AspectRat TFF3Human TFF3Research Implications
Primary GI expressionIntestine and colonIntestine and colonConserved digestive function
Lymphoid expressionPresent in lymphoid tissuesAlso observed in lymphoid tissuesImmune function studies
Sex differencesHigher in femalesHigher in femalesSex as biological variable
Response to helminth infectionModulated in sex and age-dependent mannerModulated by infectionInfection models
Association with malignancyLimited dataEstablished oncogenic functionCancer model limitations

When using rat models to study TFF3 biology with translational goals, these species-specific differences should be taken into account for proper interpretation of results and their potential relevance to human health and disease . Research on parasitic helminth infections has shown that TFF3 levels are generally higher in females and are modulated by infection in both species, although specific patterns may differ .

What experimental approaches effectively manipulate TFF3 expression in rat models?

Several approaches can be employed to manipulate TFF3 expression in rat models:

ApproachMethodologyAdvantagesLimitations
OverexpressionViral vectors with rat TFF3 geneTissue-specific with appropriate promotersPotential off-target effects
KnockdownsiRNA/shRNA targeting TFF3 mRNARelatively rapid, can be tissue-targetedIncomplete knockdown, transient
KnockoutCRISPR/Cas9 genome editingComplete elimination of gene functionTechnical complexity, potential compensation
Chemical modulationSmall molecules (e.g., AMPC)Can target specific forms (monomer vs dimer)Potential off-target effects
Recombinant administrationPurified TFF3 protein (monomer/dimer)Controlled dosing, structural variantsLimited tissue distribution

The small molecule AMPC has been identified as a compound that specifically targets TFF3 homodimeric functions by monomerizing cellular and secreted TFF3 homodimer at the Cysteine 57-Cysteine 57 residue, leading to more rapid degradation of the generated TFF3 monomers . This approach exemplifies a novel mechanism by which small molecule drugs may inhibit dimeric proteins and provides a strategy to modulate TFF3-dependent processes .

How do parasitic infections modulate TFF3 expression in rats?

Parasitic infections demonstrate complex effects on TFF3 expression in rats:

  • Helminth infections can modulate TFF3 levels in rats, though the direction and magnitude depend on:

    • Host-parasite specific interactions

    • Host factors (sex, age)

    • Tissue examined

  • Schistosoma infections have been observed to elevate TFF3 levels under certain conditions

  • TFF proteins may act upstream or in parallel with type 2 immune responses, which are critical for worm clearance and tissue repair

  • Sex differences are observed, with females generally showing higher baseline TFF3 levels and potentially different responses to infection

These findings highlight the importance of considering sex as a biological variable in TFF3 research . The modulation of TFF3 by parasitic infections suggests potential utility as a biomarker for early detection or prognosis of helminth infections, with studies in both Brazilian and Nigerian populations showing specific patterns of TFF regulation during infection .

What are the optimal experimental designs for studying TFF3's role in gastrointestinal repair in rats?

Effective experimental designs for studying TFF3's role in gastrointestinal repair in rats should incorporate:

1. Injury Models:

  • Chemical injury: DSS, TNBS, or acetic acid to induce colitis or gastric ulcers

  • Mechanical injury: Biopsy forceps or surgical procedures

  • Radiation-induced injury: For studying radioprotective effects

2. TFF3 Manipulation Approaches:

  • Administration of synthetic TFF3 variants (both monomers and dimers)

  • Genetic manipulation (overexpression or knockdown)

  • Pharmacological agents affecting TFF3 structure (e.g., AMPC for homodimer disruption)

3. Comprehensive Assessment Methods:

  • Histological analysis of tissue repair and regeneration

  • Molecular analysis of signaling pathways (EGFR, p38, STAT3, AKT, ERK)

  • Functional tests of barrier integrity

  • Analysis of inflammatory markers and cell cycle regulators

  • Apoptosis assessments (measuring CASPASE activities)

4. Time-Course Design:
Studies should incorporate multiple timepoints from acute injury through complete healing to capture the dynamic nature of TFF3's contribution to the repair process.

The trefoil domain of TFF3 appears crucial for bioactivity, as fragments containing this domain (TFF3 7-54) have demonstrated stability in simulated gastrointestinal fluids and retained anti-apoptotic activity equivalent to full-length TFF3 .

How can contradictory data regarding TFF3's pro- and anti-inflammatory effects be reconciled?

Reconciling contradictory data regarding TFF3's inflammatory effects requires consideration of several key factors:

FactorInfluence on TFF3 FunctionResearch Approach
Inflammatory contextTFF3 may have different effects in acute vs. chronic inflammationCompare effects across multiple inflammation models
Timing of actionDifferent roles during initiation vs. resolution phasesTime-course studies with multiple assessment points
Form of TFF3Monomeric vs. homodimeric forms have distinct propertiesSpecifically test each form in identical conditions
Concentration effectsDose-dependent activation of different pathwaysDose-response studies across wide concentration range
Cell/tissue specificityDifferent responses based on receptor expressionCompare effects across multiple cell/tissue types
Methodological differencesVariation in models, administration routes, and readoutsStandardize protocols and use multiple complementary approaches

Research has demonstrated that synthetic TFF3 can be produced in both monomeric and homodimeric forms with confirmed correct folding by NMR and circular dichroism . These synthetic forms enable precise manipulation of TFF3 structure and concentration to systematically evaluate potentially contradictory effects. The discovery that TFF3 maintains gut-stable metabolites (TFF3 7-54; t1/2 > 24h) that retain trefoil structure and anti-apoptotic bioactivity provides additional means to study TFF3's time-dependent effects in inflammatory contexts .

Product Science Overview

Introduction

Trefoil Factor-3 (TFF3), also known as Intestinal Trefoil Factor (ITF), is a member of the trefoil factor family (TFF) peptides. These peptides are characterized by the presence of at least one trefoil motif, a 40-amino acid domain containing three conserved disulfide bonds . TFF3 is primarily expressed in the gastrointestinal mucosa and plays a crucial role in protecting and healing the epithelial lining.

Structure and Production

The recombinant form of TFF3 (Rat) is produced in Escherichia coli and is a 7.7 kDa protein consisting of 68 amino acid residues . The protein is constructed with a 9 amino acid C-terminal fusion of Flag-Tag, which aids in its identification and purification . The amino acid sequence of TFF3 (Rat) is as follows:

MQEFVGLSPS QCMVPANVRV DCGYPTVTSE QCNNRGCCFD SSIPNVPWCF KPLQETECT F DYKDDDDK
Biological Functions

TFF3 plays several vital roles in the body, including:

  • Mucosal Protection: TFF3 stabilizes the mucus layer in the gastrointestinal tract, protecting the mucosa from various insults .
  • Epithelial Healing: It promotes the healing of the epithelial lining by inducing ciliogenesis and promoting airway epithelial ciliated cell differentiation through an epidermal growth factor receptor-dependent pathway .
  • Tumor Progression: Overexpression of TFF3 has been linked to the progression of hepatocellular carcinoma in both mice and humans .
Applications in Research

Recombinant TFF3 (Rat) is widely used in laboratory research to study its effects on cell proliferation, apoptosis, migration, and invasion. It is also used to investigate its role in various diseases, including cancer .

Storage and Stability

The lyophilized form of TFF3 (Rat) should be stored at -20°C. After reconstitution, it can be stored at 4°C for a limited period without significant changes . It is recommended to filter the reconstituted protein using an appropriate sterile filter before use in cell culture .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.